Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raju Subramanian

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Current Pharmaceutical Design|December 29, 2015
Manufacturing of [(14)C]-Labeled Drug Substance and Drug Product Utilized in Clinical Research: A Case Study of Omecamtiv MecarbilScott W Roberts, Jeroen M Bezemer, Michael T Kennedy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2012
Regiospecific and stereospecific triangulation of the structures of metabolites formed by sequential metabolism at multiple prochiral centersRobert J Greene, John A Davis, Raju Subramanian, et al.
Annals of Pediatric Cardiology|October 20, 2021
Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradineBalaganesh Karmegaraj, Seshadri Balaji, Prasanna Narayanan Raju, et al.
Molecular Pharmacology|August 21, 2015
Critical Cysteine Residues in Both the Calcium-Sensing Receptor and the Allosteric Activator AMG 416 Underlie the Mechanism of ActionShawn T Alexander, Thomas Hunter, Sarah Walter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 18, 2009
In vitro metabolism of the novel, highly selective oral angiogenesis inhibitor motesanib diphosphate in preclinical species and in humansChun Li, Mita Kuchimanchi, Dean Hickman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2015
Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell FunctionUlrike Kaufmann, Patrick J Shaw, Lina Kozhaya, et al.
Journal of Immunological Methods|March 10, 2017
Clinical immunogenicity of the d-amino acid peptide therapeutic etelcalcetide: Method development challenges and anti-drug antibody clinical impact assessmentsMark A Kroenke, Dohan K Weeraratne, Hongjie Deng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 16, 2002
Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonizationThomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, et al.
Chemical Research in Toxicology|July 14, 2022
<sup>18</sup>O-Enabled High-Throughput Acyl Glucuronide Stability AssayZaikuan Josh Yu, Hoa Le, Jennifer Tang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 8, 2026
Encequidar is a multispecies gut-restricted P-glycoprotein inhibitor that delineates between intestinal secretion and biliary elimination in animals and predicts human disposition pathwaysMurali Subramanian, Josh Yu, Gregg Schwarzwalder, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Current Pharmaceutical Design|December 29, 2015
Manufacturing of [(14)C]-Labeled Drug Substance and Drug Product Utilized in Clinical Research: A Case Study of Omecamtiv MecarbilScott W Roberts, Jeroen M Bezemer, Michael T Kennedy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2012
Regiospecific and stereospecific triangulation of the structures of metabolites formed by sequential metabolism at multiple prochiral centersRobert J Greene, John A Davis, Raju Subramanian, et al.
Annals of Pediatric Cardiology|October 20, 2021
Tachycardia-induced cardiomyopathy secondary to incessant ectopic atrial tachycardia in two infants: Potential new indication for early initiation of enteral ivabradineBalaganesh Karmegaraj, Seshadri Balaji, Prasanna Narayanan Raju, et al.
Molecular Pharmacology|August 21, 2015
Critical Cysteine Residues in Both the Calcium-Sensing Receptor and the Allosteric Activator AMG 416 Underlie the Mechanism of ActionShawn T Alexander, Thomas Hunter, Sarah Walter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 18, 2009
In vitro metabolism of the novel, highly selective oral angiogenesis inhibitor motesanib diphosphate in preclinical species and in humansChun Li, Mita Kuchimanchi, Dean Hickman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2015
Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell FunctionUlrike Kaufmann, Patrick J Shaw, Lina Kozhaya, et al.
Journal of Immunological Methods|March 10, 2017
Clinical immunogenicity of the d-amino acid peptide therapeutic etelcalcetide: Method development challenges and anti-drug antibody clinical impact assessmentsMark A Kroenke, Dohan K Weeraratne, Hongjie Deng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 16, 2002
Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonizationThomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, et al.
Chemical Research in Toxicology|July 14, 2022
<sup>18</sup>O-Enabled High-Throughput Acyl Glucuronide Stability AssayZaikuan Josh Yu, Hoa Le, Jennifer Tang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 8, 2026
Encequidar is a multispecies gut-restricted P-glycoprotein inhibitor that delineates between intestinal secretion and biliary elimination in animals and predicts human disposition pathwaysMurali Subramanian, Josh Yu, Gregg Schwarzwalder, et al.
Pageof 8